Clare Cutland

Publications

181

Citations

16.2K

h-index

54

Publishing journals

62

Years of publications

20+

Active since

2007

References

6.3K

1. Persistence of Antibodies at Three, Four and Five Years of Age to Ten-valent Pneumococcal Polysaccharide Protein D-conjugate Vaccine in South African Children According to HIV Status.
   The Pediatric infectious disease journal, Volume 45, Issue 2, Pages 173-180 173-180, Year 2026
2. Sero-epidemiology of measles immunoglobulin G antibodies among newborns from South-East Asia and sub-Saharan Africa: an observational, multicenter study
   International Journal of Infectious Diseases, Volume 154, Pages 107882-107882, Year 2025
3. Epidemiology of Group B Streptococcus : Maternal Colonization and Infant Disease in Kampala, Uganda
   Open Forum Infectious Diseases, Volume 12, Issue 4, No. ofaf167, Year 2025
4. Longitudinal Meta-cohort study protocol using systems biology to identify vaccine safety biomarkers
   Vaccine, Volume 62, Pages 127504-127504, Year 2025
5. Vaccine Utilization and Timing of Administration in Pregnant Women: A South African Perspective
   The Pediatric Infectious Disease Journal, Volume 44, Issue 2S, Pages S85-S89, Year 2025
6. From colonization to causation: the links between Group B Streptococcus colonization, invasive disease, and preterm birth
   International Journal of Epidemiology, Volume 54, Issue 1, No. dyaf002, Year 2025
7. Fostering Collaboration Across Nations: Report of the 6th International Neonatal and Maternal Immunization Symposium (INMIS), Costa Rica, 2024
   Pediatric Infectious Disease Journal, Volume 44, Issue 2S, Pages S2-S8, Year 2025
8. Serotype-specific serum immunoglobulin G at 18 months of age following one or two doses of a primary series of 10-valent or 13-valent pneumococcal conjugate vaccine and a booster dose at nine months of age: a randomized controlled study
   Expert Review of Vaccines, Volume 24, Issue 1, Pages 121-127, Year 2025
9. Corrigendum to “Defining and reporting adverse events of special interest in comparative maternal vaccine studies: a systematic review”. [Vaccine X, 2024 Feb 23;18:100464] (Vaccine: X (2024) 18, (S2590136224000378), (10.1016/j.jvacx.2024.100464))
   Vaccine: X, Volume 23, No. 100612, Pages 100612-100612, Year 2025
10. Development and validation of a novel clinical risk score to predict hypoxaemia in children with pneumonia using the WHO PREPARE dataset.
    BMJ global health, Volume 10, Issue 7, Pages e017256-e017256, Year 2025
11. Consensus study on factors influencing the academic entrepreneur in a middle-income country’s university enterprise
    Journal of Entrepreneurship in Emerging Economies, Volume 16, Issue 5, Pages 1409-1430, Year 2024
12. Burden of Lassa fever disease in pregnant women and children and options for prevention
    Vaccine, Volume 43, Issue Pt 1, Pages 126479-126479, Year 2024
13. High-resolution African HLA resource uncovers HLA-DRB1 expression effects underlying vaccine response
    Nature Network Boston, Volume 30, Issue 5, Pages 1384-1394, Year 2024
14. Obstetric and neonatal outcomes in South Africa
    Vaccine, Volume 42, Issue 6, Pages 1352-1362, Year 2024
15. Defining and reporting adverse events of special interest in comparative maternal vaccine studies: a systematic review
    Vaccine: X, Volume 18, No. 100464, Page 100464, Year 2024
16. Assessing New York City’s COVID-19 Vaccine Rollout Strategy: A Case for Risk-Informed Distribution
    Journal of urban health : bulletin of the New York Academy of Medicine, Volume 101, Issue 5, Pages 923-933, Year 2024
17. ChAdOx1 nCoV-19 (AZD1222) vaccine-induced Fc receptor binding tracks with differential susceptibility to COVID-19
    Nature Immunology, Volume 24, Issue 7, Pages 1161-1172, Year 2023
18. Durability of ChAdOx1 nCoV-19 (AZD1222) vaccine and hybrid humoral immunity against variants including omicron BA.1 and BA.4 6 months after vaccination (COV005): a post-hoc analysis of a randomised, phase 1b–2a trial
    The Lancet Infectious Diseases, Volume 23, Issue 3, Pages 295-306, Year 2023
19. Single priming and booster dose of ten-valent and 13-valent pneumococcal conjugate vaccines and Streptococcus pneumoniae colonisation in children in South Africa: a single-centre, open-label, randomised trial
    The Lancet Child & Adolescent Health, Volume 7, Issue 5, Pages 326-335, Year 2023
20. T-cell responses induced by ChAdOx1 nCoV-19 (AZD1222) vaccine to wild-type severe acute respiratory syndrome coronavirus 2 among people with and without HIV in South Africa
    AIDS (London), Volume 37, Issue 1, Pages 105-112, Year 2023

No publications in the index yet.